BIOVF News and Press, Swedish Orphan Biovit Ord From 04/30/20

The China National Medical Products Administration has approved Dova Pharmaceuticals' Doptelet (avatrombopag) for chronic liver disease patients with thrombocytopenia (low blood platelets) who are undergoing a procedure. More news on: Swedish Orphan Biovitrum AB (publ), Healthcare stocks...

The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2020 Q1 earnings Read more ...

STOCKHOLM , April 22, 2020 /PRNewswire/ --  On 29 April, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2020. Financial analysts and media are invited to participate in a telephone conference, which will include a pre...

STOCKHOLM , April 22, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has today announced the launch by its affiliate, Florio GmbH, of Florio®, a digital medical device designed with the aim to improve the quality of life for people with haemophilia. Consist...

STOCKHOLM , April 20, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) hereby informs that the shareholders may exercise their voting rights at the 2020 annual general meeting by voting in advance, so-called postal voting. Sobi urges shareholders to exercise this o...

Swedish Orphan Biovitrum ( OTCPK:BIOVF ) announced that the preliminary revenue and EBITA in March are impacted by increases in demand related to the ongoing COVID-19 pandemic. More news on: Swedish Orphan Biovitrum AB (publ), , Read more ...

The European Medicines Agency's advisory group CHMP has adopted positive opinions recommending label extensions for the following drugs: More news on: Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Healthcare stocks news, Read more ...

STOCKHOLM , Feb. 28, 2020 /PRNewswire/ -- According to a new survey from rare disease company Sobi, 28 per cent of people living with a rare condition, and their caregivers, say the disease has caused a relationship to end. 41 percent state that a rare disease has prevented them from sta...

Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2019 Earnings Conference Call February 13, 2020 4:00 AM ET Company Participants Guido Oelkers – Chief Executive Officer Henrik Stenqvist – Chief Financial Officer Milan Zdravkovic – Head-Research and Development ...

The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2019 Q4 earnings Read more ...